Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome

NCT01601028 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01601028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01601028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Hydroxychloroquine Treatment of Dry Eyes in Patients With Primary Sjögren's Syndrome
Lead sponsor
Seoul National University Hospital
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2011
Completion date
August 31, 2013
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, dry eye, sjogren's syndrome